ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,225,817 | -7.8% | 33,142 | -7.1% | 0.01% | 0.0% |
Q2 2023 | $2,414,674 | +9.5% | 35,662 | -12.5% | 0.01% | 0.0% |
Q1 2023 | $2,204,954 | -16.0% | 40,757 | -7.1% | 0.01% | -16.7% |
Q4 2022 | $2,624,524 | +56.4% | 43,881 | +18.3% | 0.01% | +50.0% |
Q3 2022 | $1,678,000 | -28.6% | 37,092 | -11.5% | 0.00% | -33.3% |
Q2 2022 | $2,350,000 | -26.0% | 41,922 | -6.2% | 0.01% | 0.0% |
Q1 2022 | $3,177,000 | -2.0% | 44,677 | -10.0% | 0.01% | 0.0% |
Q4 2021 | $3,241,000 | -52.2% | 49,657 | -45.0% | 0.01% | -57.1% |
Q3 2021 | $6,775,000 | -3.5% | 90,292 | +0.4% | 0.01% | 0.0% |
Q2 2021 | $7,019,000 | -5.5% | 89,957 | -0.8% | 0.01% | -12.5% |
Q1 2021 | $7,427,000 | +4.9% | 90,682 | +5.9% | 0.02% | 0.0% |
Q4 2020 | $7,079,000 | -10.1% | 85,599 | -29.4% | 0.02% | -20.0% |
Q3 2020 | $7,875,000 | -27.8% | 121,182 | -31.2% | 0.02% | -33.3% |
Q2 2020 | $10,903,000 | +21.7% | 176,052 | +25.8% | 0.03% | 0.0% |
Q1 2020 | $8,959,000 | -58.4% | 139,922 | -54.9% | 0.03% | -47.4% |
Q4 2019 | $21,513,000 | – | 310,572 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
RK Capital | 179,800 | $13,492,000 | 2.55% |
Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |